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Abstract 
Although the function and physiology of sleep have not been fully elucidated, it is a universal need for life-forms 
such as human beings, and in the absence of sleep, severe physiological consequences emerge. Sleep can be defined 
as temporary, partial and periodic disappearance of the organism’s communication with the environment and it is 
reversible with various severity stimuli. Sleep disorders in hemodialysis patients are frequently seen with the 
contribution of various risk factors. Insomnia is the most common sleep disorder in hemodialysis patients and affects 
the sleep quality of patients negatively. Insomnia is a lack of adequate and restful sleep despite adequate reserved 
time to sleep and it refers to sleeplessness. Sleeplessness can be defined as difficulty in starting sleep, and it refers 
insufficiency in duration, integrity and quality of sleep despite there is adequate time and chance to sleep. Anemia, 
anxiety, depression and many factors cause sleep disorders in hemodialysis patients. The aim of this review is to 
give information about the prevalence of common sleep disorders in hemodialysis patients and the risk factors that 
contribute to the development of these disorders. 
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Introduction 
 
Hemodialysis [HD]is the process of taking toxin loaded 
blood from the patient via an artificial membrane and 
HD machine, regulating liquid-electrolyte content of 
blood and giving it to the patient again [1-3]. In the 
early years of HD, it was used only for patients with 
severe uremic and terminal periods. However, with the 
technical development of HD treatment, ease of 
accessibility to HD and the fact that HD costs can be 
covered by health insurance, the frequency of this 
method has increased [4]. The dialysis process can be 
applied as standard HD, short daily HD, night long HD 
and home HD [4-6]. Standard HD treatment is the main 
treatment option for ESRF [End-Stage Renal Failure] 
patients in the world [5].  
Definition, Stages and Physiology of Sleep 
Although the function and physiology of sleep have not 
been fully elucidated, it is a universal need for life-
forms such as human beings, and in the absence of 
sleep, severe physiological consequences emerge. 
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Sleep can be defined as temporary, partial and periodic 
disappearance of the organism’s communication with 
the environment and it is reversible with various 
severity stimuli [7]. Sleep consists of two different 
stages in terms of cardiovascular effect. The first is 
NREM [non-rapid eye movement] sleep without rapid 
eye movements and the second is REM [rapid eye 
movement] sleep with rapid eye movements. 70-80% 
of the normal sleep period consists of NREM [6 hours] 
period and 20-25% [1,5-2 hours] consists of REM 
period. Non-REM sleep is divided into four stages and 
REM sleep is divided into two stages as phasic and 
tonic [8]. Stages of Non-REM Sleep; 
 Stage 1: Constitutes 1-5% of all night sleep. It is 
a period of falling asleep and it has short 
duration. Brain activity is high at this stage, 
accompanied by relaxation and slow eye 
movements [8, 9]. 
 Stage 2: Constitutes 40-50% of all night sleep. It 
is the longest stage of sleep. There are brain 
activities that provide continuity of sleep [8, 9]. 
 Stage 3: Constitutes 3-8% of all night sleep [8]. 
 Stage 4: Constitutes 10-15% of all night sleep. 
Stage 3 and stage 4 are deep sleep stages [10]. 
In the tonic phase of REM sleep, atony occurs in 
skeletal muscle groups and reflexes are suppressed. 
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Blood pressure and heart rate fluctuations occur in the 
phasic stage characterized by rapid eye movements. In 
addition, irregular breathing, movement in the tongue, 
jaw and leg muscles are observed in this stage [9]. 
Normal sleep begins with stage 1 and then passes to 
stage 2. The frequency and height of brain waves are 
reduced in stage 1. In this process, the activity of the 
mind detaches from the conscious state, the person 
becomes distracted, and detaches from the outer 
environment. It then moves to stage 2, during which 
the sleeping spindles which ensure the continuity of 
sleep and the so-called K-complex regenerating brain 
activity are observed and these activities ensure that 
sleep is maintained. After the onset of sleep, the first 
REM period occurs after 70-90 minutes and this cycle 
is renewed every 90 minutes. REM sleep occurs in 4-6 
separate episodes overnight [10, 11]. 
The cortical and subcortical areas of the brain are 
involved in initiating and sustaining sleep. 
Borbely[2001] describes the sleep-wake cycle in a dual 
process model. According to the model, the sleep-wake 
cycle occurs with the effect of cyclic and homeostatic 
factors. Cyclic factors make the tendency to sleep more 
or less in certain segments of the day. The hourly cycle 
formed by the day-night change is controlled by the 
suprachiasmatic nuclei which are bilateral in the 
hypothalamus. Homeostatic sleep impulse increases as 
the time spent awake increases [12]. 
Classification of Sleep Disorders 
Sleep disorders were first classified in 1979 under the 
heading of Diagnostic Classification of Sleep and 
Arousal Disorders. This classification includes three 
main headings: sleep disorders insomnia, daytime 
sleepiness and abnormal sleep behavior. In the 
following years, the American Sleep Disorders 
Association published the International Classification 
of Sleep Disorders (ICSD). In the second edition of 
International Classification of Sleep Disorders (ICSD-
2, 2004), the clinical characteristics and definitive 
diagnostic criteria of 85 diseases are specified. ICSD-2 
includes eight sub-titles [13, 14]. 
Common Sleep Disorders in Hemodialysis Patients 
Insomnia is the most common sleep disorder in ESRF 
and HD patients with a rate of 65.9-69.1%. This is 
followed by excessive daytime sleepiness, obstructive 
sleep apnea syndrome, snoring, nightmares, narcolepsy 
and sleepwalking. The table-1 shows the risk factors 
that cause sleep disorders in dialysis patients.  
Table 1: Common Sleep Disorders and Risk Factors in Hemodialysis Patients 
Sleep Disorder Prevalence Risk Factors 
Insomnia  %40-69.5  Advanced age 
 Anemia 
 Anxiety  
 Depression  
 Restless Leg Syndrome 
 Dialysis shift is an important risk factor. The insomnia 
ratio is significantly higher especially in those taking 
HD treatment in the afternoon than morning and 
evening.  
 Obstructive Sleep Apnea Syndrome 
 Excessive Daytime Sleepiness 
Excessive Daytime 
Sleepiness 
 %27  Low Hemoglobin Level 
 Presence of obstructive sleep apnea syndrome 
Obstructive Sleep 
Apnea Syndrome 
 The risk of OSAS 
development in HD 
patients is between 
31.8-71%. 
 Prevalence in HD 
patients; 37% in 
female, 34% in 
male. 
 Age, elderly patients have higher risk of sleep apnea 
than young ones. 
 Shift when dialysis applied, patients who underwent 
hemodialysis in the morning shift have higher risk 
when compared with those applied in the afternoon 
and evening 
 Obesity increases the risk of sleep apnea 
 Smoking increases the risk of sleep apnea.  
 Dialysis insufficiency increases the risk of sleep 
apnea. 
Restless Leg  %26.6-%50  Gender [RLS is seen more common in women] 
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Syndrome  Age [the average age of patients with RLS is higher] 
 Presence of RLS in family history 
 Unemployment 
 Body Mass Index 
 History of Cardiovascular Disease 
 Hypertension 
 Antihypertensive drug use 
 Presence of peripheral neuropathy 
 Serum creatinine level 
 Thyroid Gland Dysfunction  
Periodic Limb 
Movement Disorder 
[PLMD] 
%14.7  Restless Leg Syndrome 
 
Insomnia  
Insomnia is defined as a complaint of inadequate and 
restful sleep although enough time is left for sleep [15]. 
Insomnia refers to sleeplessness. Sleeplessness can be 
defined as difficulty in starting sleep, and it refers 
insufficiency in duration, integrity and quality of sleep 
despite there is adequate time and chance to sleep.  
Complaints about insomnia in adults; 
 Difficulty in starting to sleep or maintaining 
sleep. 
 Increased time of awakening in night. 
 Concerns about insufficient sleep duration. 
 Feeling that sleep is not restful. 
Insomnia may be acute or chronic depending on 
duration. Acute insomnia lasts less than four weeks and 
chronic insomnia lasts longer than 6 months [16]. 
Insomnia is the most commonly reported sleep disorder 
in the general population and its prevalence is between 
4.4-11.7% [17]. In a study by Al-Jahdali et al. [2010], 
HD patients with insomnia were reported to have poor 
sleep quality as measured by PSQI. Studies show that 
insomnia is the most common sleep disorder in HD 
patients [18-20]. According to studies, the prevalence 
of insomnia is reported to be between 40-69.5% in 
patients receiving HD treatment [18-23]. In other 
words, this sleep disorder is 4-6 times more common in 
HD patients than the general population. In addition, 
HD treatment is considered as an independent risk 
factor in the development of insomnia [22]. Al-Jahdali 
et al. [2010] reported that the sleep quality of HD 
patients diagnosed with insomnia is poor [23]. The risk 
factors causing insomnia in patients receiving HD 
treatment are listed below. Advanced age, anemia, 
anxiety, depression, restless leg syndrome, obstructive 
sleep apnea syndrome, excessive daytime sleepiness 
and dialysis shift (the insomnia ratio is significantly 
higher in those taking HD treatment in the afternoon 
than morning and evening) are important risk factors in 
the formation of insomnia in HD patients [23-26]. 
Excessive Daytime Sleepiness 
Excessive Daytime Sleepiness is a general symptom of 
ineffective, inadequate and internal sleep disorders. 
Daytime sleepiness is the most common complaint that 
causes patients to apply to sleep clinics. Sleepiness 
affects the general health and daily function and 
determines the energy and fatigue level of the 
individual during the day [27]. Approximately 5% of 
the population has excessive daytime sleepiness. It 
causes accidents and increases the risk of death in 
individual and other people [23].  Araujo et al. [2011] 
found that excessive daytime sleepiness prevalence 
was 27% in their study conducted with 400 
hemodialysis patients. Risk factors for excessive 
sleepiness in hemodialysis patients are low hemoglobin 
level and presence of obstructive sleep apnea syndrome 
[26]. 
Obstructive Sleep Apnea Syndrome (OSAS) 
OSAS is an important sleep disorder developing due to 
recurrent respiratory disorders (apnea, hypopnea) as a 
result of the blockages in the upper airway during 
sleep. Sleeplessness due to sleep splits, hypoxemia as a 
result of upper airway obstruction, and wake-up 
reactions cause sympathetic nervous system discharge 
and this situation causes both sleep disturbance and 
cardiovascular complications. Snoring, restless sleep, 
morning headache, gastroesophageal reflux, nocturia 
and decreased libido are common symptoms of OSAS 
[28]. Although there are scales developed to detect the 
risk of sleep apnea, polysomnography is the gold 
standard method in the diagnosis. In studies using 
polysomnography, the prevalence of OSAS in patients 
receiving HD treatment is reported to be between 34.4-
65% [28-30]. According to the studies using scales, the 
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risk of OSAS development in patients receiving HD 
treatment is between 31.8-71% [18, 19, 25, 31, 32]. In 
addition, patients with high risk of developing OSAS 
have been reported to be more susceptible to insomnia, 
RLS, snoring habits and excessive daytime sleepiness 
[23]. Factors that increase the risk of OSAS in ESRD; 
Age, Dialysis shift, Obesity, Smoking, Dialysis 
insufficiency [23, 32]. 
Restless Leg Syndrome 
Restless Legs Syndrome (RLS) is defined as a common 
neurological disorder that may be primary or 
secondary, containing emotional and motor 
components. Pathophysiological mechanisms of central 
nervous system causing RLS are not fully known 
[33].According to a study conducted in Turkey, RLS is 
seen in 30.8% of patients received dialysis treatment 
[34].In a study by Al-Jahdali et al. (2010), the 
prevalence of RLS is reported to be 50% in ESRD 
patients [23].In a study conducted by Stefanidis et al. 
(2013), it was reported that the prevalence of RLS was 
26.6% in HD patients and that more than 80% of 
patients with RLS experienced mild or moderate 
symptoms and 16.2% were severe or very severe [35]. 
According to a study conducted by Rohani et al. [2014] 
in Iran, sleep complaints of HD patients with RLS are 
reported to be more frequent. These complaints include 
decreased sleep time, increased dozing off duration, 
excessive daytime sleepiness, insomnia and frequent 
consumption of sedative-hypnotic agents [36]. In a 
study to determine RLS-related sleep disorders, RLS 
has been reported to be associated with excessive 
daytime sleepiness, poor sleep quality and insomnia 
[37]. In addition, RLS causes sleep deprivation, 
excessive daytime sleepiness, depression in patients 
with chronic renal failure and in this group, RLS 
decreases quality of life and increases mortality [38]. 
Risk factors of RLS in HD patients; gender [RLS is 
seen more common in women], age [the average age of 
patients with RLS is higher], presence of RLS in 
family history, unemployment, body mass index, 
history of cardiovascular disease, hypertension, 
antihypertensive drug use, presence of peripheral 
neuropathy, serum creatinine level and thyroid gland 
dysfunction [34-37].  
Periodic Limb Movement Disorder 
Periodic limb movement disorder [PLMD] was first 
described by Symonds in 1953 as nocturnal 
myoclonus, which is characterized by periodic 
repetitive foot, leg and / or arm movements during 
sleep. The etiology of the disease has not been fully 
elucidated. PLMD can be a primary disease and may 
accompany other sleep disorders. The prevalence of 
PLMD in the population is 3.9% and it is more 
common in women. PLMD is associated with restless 
leg syndrome and 80% of patients with RLS have 
PLMD [39]. Hsu et al. [2008] reported the prevalence 
of PLMD in HD patients as 14.7% [40]. Restless leg 
syndrome is the most important risk factor in PLMD. 
Conclusion 
Sleep disorders in HD patients negatively affect sleep 
quality of patients. The most common sleep disorders 
in hemodialysis patients are insomnia. Obstructive 
Sleep Apnea Syndrome, Excessive Daytime 
Sleepiness, Restless Legs Syndrome, Periodic Limb 
Movement Disorder (PLMD) are other common sleep 
related disorders in hemodialysis patients. 
Hemodialysis treatment is one of the main risk factors 
for sleep disorders. Advanced age, gender, family 
history, anemia, anxiety, depression, restless leg 
syndrome, dialysis shift, obesity, body mass index, 
smoking, dialysis insufficiency, history of 
cardiovascular disease, hypertension, antihypertensive 
drug use and thyroid gland dysfunction are important 
risk factors. 
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